what is the standard dose of semaglutide dosing guidelines for 2026 A newly approved 7.2-mg dose

Implications for Semaglutide Users For individuals using semaglutide, this information offers reassurance that their medication is unlikely to cause issues in drug testing scenarios under standard protocols

A metanalysis by Bray et al

Agarwal A, Gupta S, Sharma RK

WEEKLY MONITORING We track your progress and adjust as needed

While protein and fibre tend to get most of the attention, healthy fats play a complementary role by slowing digestion, increasing meal satisfaction, and supporting heart and metabolic health

On Wednesday, the Food and Drug Administration issued a warning, calling compounded GLP-1 medications "risky for patients." "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said